ResearcherFourth Hospital of Hebei Medical UniversityNo recent work listed
Meixiang Sang
Matched on ORCID iD 0000-0001-8295-8463; OpenAlex author ID A5032448790, A5062925533. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper
Papers 4
- Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations. Last author DOI 10.1186/s12885-018-4217-9↗
- Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 … Co-author DOI 10.1371/journal.pone.0179884↗
- Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TA… Co-author DOI 10.18632/oncotarget.12433↗
- Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Co-author DOI 10.1038/cddis.2015.242↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toshinori Ozaki · 4 shared papers, 2015–2018 · strength 0.27
- Paper Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations. DOI 10.1186/s12885-018-4217-9↗
- Paper Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cel… DOI 10.1371/journal.pone.0179884↗
- Paper Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells t… DOI 10.18632/oncotarget.12433↗
- Mizuyo Nakamura · 3 shared papers, 2015–2017 · strength 0.18
- Paper Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cel… DOI 10.1371/journal.pone.0179884↗
- Paper Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells t… DOI 10.18632/oncotarget.12433↗
- Paper Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the s… DOI 10.1038/cddis.2015.242↗
- Osamu Shimozato · 3 shared papers, 2015–2017 · strength 0.18
- Paper Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cel… DOI 10.1371/journal.pone.0179884↗
- Paper Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells t… DOI 10.18632/oncotarget.12433↗
- Paper Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the s… DOI 10.1038/cddis.2015.242↗
- Meijie Sang · 2 shared papers, 2016–2017 · strength 0.13
- Paper Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cel… DOI 10.1371/journal.pone.0179884↗
- Paper Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells t… DOI 10.18632/oncotarget.12433↗
- Takehiro Ogata · 2 shared papers, 2016–2017 · strength 0.13
- Paper Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cel… DOI 10.1371/journal.pone.0179884↗
- Paper Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells t… DOI 10.18632/oncotarget.12433↗
- Hirokazu Sugimoto · 1 shared paper, 2015 · strength 0.05
- Hiroki Nagase · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.